Absci (ABSI) Times Interest Earned (2020 - 2026)
Absci's (ABSI) quarterly Times Interest Earned came in at -$1713.7 in Q1 2026, down 388.22% year-on-year from $594.56 in Q1 2025, and down 60.1% quarter-over-quarter from -$1070.4 in Q4 2025.
Absci (ABSI) Times Interest Earned (2020 - 2026) Analysis & Trends
Absci has disclosed Times Interest Earned across 7 years of filings, most recently posting -$1713.7 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$1713.7, down 388.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$834.01 (down 245.05% YoY), and the FY2025 annual result was -$575.68, down 198.71% from the prior year.
- Times Interest Earned came in at -$1713.7 for Q1 2026 at Absci, down from -$1070.4 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$73.49 in Q4 2022 to a low of -$1713.7 in Q1 2026.
- The 5-year median for Times Interest Earned is -$167.92 (2023), against an average of -$358.73.
- Across the five-year window, Times Interest Earned plunged 1547.75% in 2022 and surged 48.36% in 2023, its largest moves.
- Absci's Times Interest Earned stood at -$73.49 in 2022, then sank by 65.0% to -$121.27 in 2023, then sank by 125.25% to -$273.16 in 2024, then tumbled by 291.86% to -$1070.4 in 2025, then slumped by 60.1% to -$1713.7 in 2026.
- The last three Times Interest Earned figures came in at -$1713.7 (Q1 2026), -$1070.4 (Q4 2025), and -$670.09 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -1,713.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,713.67 |
| Dec 31, 2025 | -1,070.38 |
| Sep 30, 2025 | -670.09 |
| Jun 30, 2025 | -560.59 |
| Mar 31, 2025 | -351.00 |
| Dec 31, 2024 | -273.16 |
| Sep 30, 2024 | -222.27 |
| Jun 30, 2024 | -178.14 |
| Mar 31, 2024 | -133.51 |
| Dec 31, 2023 | -121.27 |
| Sep 30, 2023 | -101.76 |
| Jun 30, 2023 | -167.92 |
| Mar 31, 2023 | -76.28 |
| Dec 31, 2022 | -73.49 |
| Sep 30, 2022 | -100.24 |
| Jun 30, 2022 | -136.91 |
| Mar 31, 2022 | -147.71 |
| Dec 31, 2021 | -131.28 |
| Sep 30, 2021 | -27.53 |
| Jun 30, 2021 | -8.31 |